Digital blood pressure monitor hem 907

The measurements of blood pressure, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were conducted using a digital sphygmomanometer (Omron Digital Blood Pressure Monitor HEM-907, Matsusaka, Japan). Resting heart rate (HR_rest) was also measured. These measurements were taken three times under the same conditions in a seated resting position and with the left arm in support, after at least 5 min (AHA, 2005). A scale (OMRON BF 303, Matsusaka, Japan), a stadiometer (Seca, Hamburg, Germany), and bioelectrical impedance analysis were used for body mass (kg), height (cm), and body mass index (BMI, kg·m⁻²) and body fat percentage (BF, %), respectively.

Brachial blood pressure was measured in triplicate in the supine position by an automated sphygmomanometer (Omron Digital Blood Pressure Monitor HEM907, Bannockburn, IL). Mean arterial pressure (MAP) and pulse pressure (PP) were calculated from systolic blood pressure (SBP) and diastolic blood pressure (DBP) values according to the following formulas:
MAP = (SBP + 2 × DBP)/3 and PP = SBP − DBP.
Ao-PWV was determined from carotid and femoral pressure waveforms obtained noninvasively by applanation tonometry (Millar tonometer, Millar Instruments, Houston, TX) using the Sphygmocor system (Atcor, Sydney, Australia) as previously described.¹⁵ (link) The distance between the surface markings of the sternal notch and the carotid (dc) and femoral artery (df) were used to estimate the path length between the carotid and femoral arteries (L= df-dc)) and Ao-PWV was computed as L/ΔT.¹⁵ (link) The within-subject SD of Ao-PWV assessed by this method was 0.5 m/s in our laboratory. The intraobserver coefficient of variation was 3.5%.

Body mass (kg), body fat percentage (%BF, %) and body mass index (BMI, kg.m⁻²) were assessed through a bioelectrical impedance analysis (OMRON BF 303, Matsusaka, Japan), and height was assessed with a stadiometer (Seca, Hamburg, Germany) for the body compositions.
For the hemodynamic profiles, blood pressure and resting heart rate (RHR) were measured three times in a seated rest position with the left arm in support (AHA, 2005), with an Omron Digital Blood Pressure Monitor HEM-907 (Matsusaka, Japan).
The lipid profiles were collected according to the Diabetes Atlas Committee’s procedures for measurement of triglycerides (TG, mg/dL), total cholesterol (TC, mg/dL) and blood glucose (GL, mg/dL) with the use of Roche Diagnostics GmbH Cobas Accutrend Plus (Mannheim, Germany).